REGENERON PHARMACEUTICALS, INC.

• REGENERON PHARMACEUTICALS, INC $4,050,000 In-house, the client's own filings · 7 filings
• CHECKMATE GOVERNMENT RELATIONS $570,000 Outside firm · 8 filings
• BGR GOVERNMENT AFFAIRS $540,000 Outside firm · 7 filings
• CRANE STRATEGIES $350,000 Outside firm · 7 filings
• THE WASHINGTON TAX & PUBLIC POLICY GROUP $210,000 Outside firm · 8 filings
• ARNOLD & PORTER KAYE SCHOLER LLP $60,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 1990
  American Innovation and R&D Competitiveness Act of 2025
  4 filings
• H.R. 1
  One Big Beautiful Bill Act
  3 filings
• S. 1649
  Sporting Goods Excise Tax Modernization Act
  3 filings

• 2026 $2,700,000 18 filings
• 2025 $3,080,000 26 filings

• Health Issues 25
• Taxation/Internal Revenue Code 15
• Budget/Appropriations 8
• Copyright/Patent/Trademark 7
• Medicare/Medicaid 7
• Trade (domestic/foreign) 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• SENATE 26
• HOUSE OF REPRESENTATIVES 25
• Health & Human Services, Dept of (HHS) 20
• Centers For Medicare and Medicaid Services (CMS) 10
• White House Office 3
• Food & Drug Administration (FDA) 2
• Treasury, Dept of 2
• Commerce, Dept of (DOC) 1
• U.S. Trade Representative (USTR) 1